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e have previously shown that the neurotrophic
effect of glial cell line–derived neurotrophic
factor (GDNF) in vitro and in vivo requires the
 
presence of transforming growth factor (TGF)
 
 
 
. Using primary
neurons (chick E8 ciliary) we show that the combination of
GDNF plus TGF
 
 
 
 promotes survival, whereas the single
factors do not. This cooperative effect is inhibited by blocking
the extracellular signal-regulated kinase (ERK)/MAPK path-
way, but not by interfering with the PI3 kinase signaling
cascade. Although there is no functional GDNF signaling
W
 
in the absence of TGF
 
 
 
, pretreatment with TGF
 
 
 
 confers
GDNF responsiveness to the cells. This is not due to up-
regulation of GDNF receptors mRNA and protein, but to
TGF
 
 
 
-induced recruitment of the glycosyl-phosphatidyl-
inositol-anchored GDNF receptor (GFR)
 
 
 
1 to the plasma
membrane. This is supported by the fact that GDNF in the
presence of a soluble GFR
 
 
 
1 can promote survival in the
absence of TGF
 
 
 
. Our data suggest that TGF
 
 
 
 is involved
in GFR
 
 
 
1 membrane translocation, thereby permitting
GDNF signaling and neurotrophic effects.
 
Introduction
 
Neurotrophic factors are a broad set of peptide growth
factors that tightly regulate development and survival of
neurons of the central nervous system (CNS)* and the periph-
eral nervous system (for review see Huang and Reichardt,
2001; Neet and Campenot, 2001). Among the expanding
list of neurotrophic factors, the discovery of glial cell line–
derived neurotrophic factor (GDNF) as a survival and dif-
ferentiation factor for midbrain dopaminergic neurons was a
hallmark in the search for novel molecules that may have
relevance in the treatment of neurodegenerative diseases,
e.g., Parkinson’s disease (PD) (Lin et al., 1993). The signifi-
cance of GDNF is underscored by its efficacy in several
animal models of PD, including: nonhuman primates (Hoffer
et al., 1994; Beck et al., 1995; Sauer et al., 1995; Tomac et
al., 1995; Gash et al., 1996); ubiquitous expression in neurons
of the CNS (Pochon et al., 1997) and its widening spectrum
of responsive neuron populations (Henderson et al., 1994;
Arenas et al., 1995; Buj-Bello et al., 1995; Trupp et al.,
1995; Farkas et al., 1997). GDNF is a member of the
transforming growth factor (TGF)
 
 
 
 superfamily (Kingsley,
1994), its closest relative being neurturin (Kotzbauer et al.,
1996). Targeted mutations of GDNF (Moore et al., 1996;
Pichel et al., 1996; Sanchez et al., 1996) or its receptors,
c-Ret (Schuchardt et al., 1994) and GDNF receptor (GFR)-
 
 
 
1
(Cacalano et al., 1998; Enomoto et al., 1998), have indi-
cated that GDNF is essentially required for the development
of the kidney, major portions of the enteric nervous system,
and the sympathetic superior cervical ganglion. Recently,
Ret has been described as a key regulator of migration of
neuronal precursors of the sympathetic nervous system
(Enomoto et al., 2001). However, most strikingly, it has
been shown that GDNF is not trophically active unless
supplemented with TGF
 
 
 
 in vitro and in vivo (Krieglstein
et al., 1998; Schober et al., 1999).
TGF
 
 
 
s are widely distributed cytokines with prominent
roles in development and cell cycle control (Roberts and
Sporn, 1990; Alexandrow and Moses, 1995; Krieglstein et
al., 1995). TGF
 
 
 
s have been implicated in the regulation of
neuronal survival of motoneurons (Martinou et al., 1990),
sensory (Chalazonitis et al., 1992), and midbrain dopaminergic
neurons (Krieglstein and Unsicker, 1994; Poulsen et al.,
1994), for example. However, TGF
 
 
 
s show no or marginal
effects on highly enriched, serum-free neuron cultures, such
as sensory neurons (Krieglstein and Unsicker, 1996), sug-
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gesting that TGF
 
 
 
 may require cooperating factors for elic-
iting its trophic effects. Along this line, TGF
 
 
 
 actions are al-
ways referred to as being contextually dependent, suggesting
that other molecules present significantly determine TGF
 
 
 
actions and vice versa (Nathan and Sporn, 1991; Unsicker
and Krieglstein, 2000). Putative contextual actions of TGF
 
 
 
s
and additional molecules may also underlie the seemingly
conflicting effects of TGF
 
 
 
 in the regulation of both sur-
vival and death of ciliary ganglionic (CG) neurons (Kriegl-
stein et al., 2000). With regard to the regulation of survival,
TGF
 
 
 
 cooperates with GDNF, whereas TGF
 
 
 
-induced cell
death may be the consequence of a lack of the appropriate
neurotrophic factor, like GDNF, or may be the result of co-
operativity with other yet unidentified cytokines.
A fundamental question regarding GDNF-TGF
 
 
 
 coop-
erativity concerns the underlying molecular mechanism.
GDNF signals via binding as a homodimer to a hetero-
tetrameric complex of two glycosyl-phosphatidylinositol
(GPI)-anchored GFR
 
 
 
1 (Jing et al., 1996;
 
 
 
Treanor et al.,
1996) and two molecules of the transmembrane tyrosine ki-
nase Ret (Durbec et al., 1996; Trupp et al., 1996). Upon au-
tophosphorylation of Ret, two signaling pathways are acti-
vated: one is the Ras/Raf/MAPK pathway, and the other
involves activation of PI3 kinase and its downstream target
PKB/Akt (Chiariello et al., 1998; Trupp et al., 1999).
The present study identifies the Ras/MAPK pathway as
the survival promoting signaling cascade activated by treat-
ment of CG neurons with GDNF and TGF
 
 
 
. We show
that TGF
 
 
 
 mediates recruitment of the GPI-linked GFR
 
 
 
1
to the site of consecutive signaling, probably lipid rafts.
 
Results
 
Survival of chick E8 CG neurons requires cooperativity 
of GDNF and TGF
 
 
 
Glial cell line–derived neurotrophic factor (GDNF) has
been described as a potent neurotrophic molecule for various
neurons of the peripheral and CNS (Lin et al., 1993; Arenas
et al., 1995; Buj-Bello et al., 1995; Farkas et al., 1997). We
have previously shown that the survival promoting effect of
GDNF in vivo and in vitro requires the presence of TGF
 
 
 
(Krieglstein et al., 1998).
In this study we have asked how the cooperation of these
two factors is mediated on the molecular level using primary
chick embryonic (E8) CG neurons as a model system. Sur-
vival of CG neurons is strictly dependent on the presence of
neurotrophic support. Fig. 1 A demonstrates that GDNF
plus TGF
 
 
 
 promotes survival of the cells, whereas the single
factors do not. This effect was dose dependent with concen-
trations of GDNF ranging from 2 to 10 ng/ml. However,
TGF
 
  
 
was almost as effective at 0.125 ng/ml as at 2 ng/ml
(Fig. 1 B). As a positive control, ciliary neurotrophic factor
(CNTF) was used, which is known to promote survival of
CG neurons independent of TGF
 
 
 
 (Krieglstein et al., 1998).
 
Inhibition of MAPK activity decreases neuronal survival 
mediated by the synergistic action of GDNF and TGF
 
 
 
To further elucidate the intracellular mechanisms underly-
ing the survival effect of GDNF in the presence of TGF
 
 
 
,
we first asked which intracellular pathway transmits the sur-
vival signal. The PI3 kinase pathway and the Ras/MAPK
signaling cascade activated by binding of GDNF to its re-
ceptors at the cell surface of responsive cells are schematically
depicted in Fig. 2 A. To clarify the involvement of these
two pathways in the cooperative survival effect of GDNF
and TGF
 
 
 
, specific inhibitors were used to block the two
signaling cascades. Wortmannin (Ward et al., 1996) and
LY294002 (Vlahos et al., 1994) were used to specifically
block the PI3 kinase downstream signaling, and the MEK
inhibitors PD98059 (Dudley et al., 1995) and U0126 (Fa-
vata et al., 1998) were employed for blocking the Ras/
MAPK pathway. Cell counts after 24 h revealed that the
neurotrophic effect of GDNF plus TGF
 
 
 
 is significantly re-
duced by blocking the ERK/MAPK pathway, but not (or
only marginally) by interfering with the PI3 kinase signaling
cascade (Fig. 2 B). To exclude a toxic effect of the inhibitors
Figure 1. GDNF-induced survival of CG neurons is strictly
dependent on the presence of TGF . CG neurons were seeded onto 
PORN/laminine-coated microtiter plates at a density of 3,000 cells 
per well. (A) Cells were treated with 10 ng/ml GDNF or 2 ng/ml 
TGF 3 or both factors. As a control the neurons were left untreated 
or CNTF (10 ng/ml) was added. (B) Cells were treated with com-
binations of the indicated concentrations of GDNF (0.5 ng/ml to 10 
ng/ml) and TGF  (0.125 ng/ml to 2 ng/ml). The cultures were fixed 
after 24 h and the numbers of surviving neurons were counted. Each 
bar represents the mean and standard deviation of at least three 
independent experiments with every condition tested in triplicate per 
assay (***, P   0.01, **, P   0.05; determined in a Student’s t test). 
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and demonstrate their specificity, CNTF and FGF-2 were
used as controls. As shown in Fig. 2 B, none of the inhibi-
tors was able to block the neurotrophic effect of CNTF.
Many functions of CNTF have been shown to be mediated
through the JAK/STAT and ERK/MAPK pathway, without
activating PI3 kinase (Boulton et al., 1994; Stahl and Yanco-
poulos, 1994; Segal and Greenberg, 1996). Apparently, the
survival signal in CG neurons does not involve ERK/
MAPK. In agreement with previous findings (Besser et al.,
1995; Piiper et al., 1996), blocking both pathways dimin-
ished FGF-2 mediated survival of CG neurons demonstrat-
ing that the inhibitors used were working properly. The
finding that the PI3 kinase pathway is not crucial for the co-
operative survival promoting effect of GDNF and TGF
 
 
 
 is
in contrast to our previous observations (Krieglstein et al.,
1998). To test whether this may be due to the fact that we
excluded insulin from the CG culture medium in the exper-
iments presented here while it was present in previous stud-
ies, we examined the effect of the kinase inhibitors on CG-
survival in the presence of insulin. In corroboration of our
previous findings, in the presence of insulin the application
of both the PI3 kinase and the MEK inhibitors decreased
the numbers of surviving neurons in the presence of GDNF
and TGF
 
 
 
 (Fig. 2 C).
 
GDNF responsiveness essentially requires 
pretreatment with TGF
 
 
 
We next tested whether TGF
 
 
 
 is required to achieve down-
stream signaling of GDNF by investigating the phosphory-
lation status of ERK and Akt in total lysates from CG neu-
rons using antibodies directed against the activated forms of
both kinases (Fig. 3 A). At 30 min there was no GDNF-
stimulated phosphorylation of ERK or Akt in the absence of
TGF
 
 
 
 or after simultaneous addition of the two factors.
Figure 2. Survival of CG neurons in 
the presence of GDNF and TGF  is 
mediated by activation of the ERK/MAPK 
pathway. (A) Simplified general scheme 
of GDNF signaling. (B) Survival of CG 
neurons in the presence of GDNF 
(10 ng/ml) and TGF 3 (2 ng/ml), FGF-2 
(10 ng/ml) or CNTF (10 ng/ml), respec-
tively, in the absence or presence of the 
kinase inhibitors Wortmannin (100 nM), 
LY294002 (5  M), U0126 (10  M), and 
PD98059 (50  M). The surviving neurons 
were counted after 24 h, each bar repre-
sents the mean and standard deviation 
of at least three independent experi-
ments with every condition tested in 
triplicate per assay (***, P   0.01; **, 
P   0.05; *P   0.1). (C) Survival assay 
as described in (B) except that insulin
(5  g/ml) was added. 
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However, treatment of CG neurons for 3 h with TGF
 
 
 
,
 
 
 
and
subsequent addition of GDNF for 30 min, lead to enhanced
phosphorylation of ERK. Interestingly, phosphorylation of
Akt was only seen if neurons were simultaneously treated
with GDNF and TGF
 
 
 
 after TGF
 
 
 
 pretreatment. Levels of
nonphosphorylated ERK were not affected by TGF
 
 
 
 pre-
treatment but remained unchanged throughout the experi-
ment; hence, they were used as a control for equal loading.
Applying the kinase inhibitors, which were used for the sur-
vival assay, proved that PD98059 could efficiently block
GDNF-induced phosphorylation of ERK without changing
Akt phosphorylation in the presence of GDNF and TGF
 
 
 
,
and Wortmannin inhibited Akt phosphorylation without af-
fecting ERK phosphorylation (Fig. 3 B). This observation
further confirmed the notion that although Wortmannin ef-
ficiently blocked Akt-phosphorylation induced by GDNF
plus TGF
 
 
 
, it did not have a major effect on survival pro-
moted by the cooperative action of the two factors.
When TGF
 
 
 
 was removed from the culture medium after
a 3-h pretreatment period by changing the medium and
adding a blocking pan-TGF
 
 
 
 antibody (blocking all three
TGF
 
 
 
 isoforms), increased phosphorylation of ERK was
still observed in the presence of GDNF (Fig. 3 C).
Corroborating this result survival of CG neurons was also
promoted when TGF
 
 
 
, initially added without GDNF, was
neutralized after 3 h and GDNF was subsequently added. In
contrast, neutralization of TGF
 
 
 
 at the beginning of the ex-
periment and administration of GDNF alone or GDNF and
Figure 3. Pretreatment with TGF  
induces GDNF responsiveness, but does 
not affect expression of the GDNF
receptors. (A) 100,000 CG neurons per 
well were plated and allowed to attach 
for 2 h. The cells were treated with 2 ng/ml 
TGF  for 3 h or left untreated as indicated. 
Subsequently no factor or GDNF (10 
ng/ml) or GDNF (10 ng/ml) plus TGF  
(2 ng/ml) were added for 30 min before 
harvesting of the cells in Laemmli sample 
buffer. (B) CG neurons were handled as in 
(A) except that PD98059 or Wortmannin 
was added to prove specific inhibition of 
ERK- and Akt-phosphorylation by the 
respective inhibitors. (C) Cells were 
pretreated for 3 h with TGF  (2 ng/ml), 
thereafter an antibody blocking all three 
TGF -isoforms (anti-pan TGF ) was 
added where indicated. 10 min later 
GDNF (10 ng/ml), TGF  (2 ng/ml) or 
both factors were added for 30 min 
and the cells subsequently harvested in 
Laemmli sample buffer. Protein extracts 
(A–C) were separated by 10% SDS-
PAGE, electroblotted onto nitrocellulose 
membranes and probed with anti–
phospho ERK-, anti–phospho Akt- or 
anti–GFR 1-antibodies. To control for 
equal loading the membrane stripped 
and probed with an antibody against 
nonphosphorylated ERK. (D) CG neurons 
were differently treated to investigate 
the requirement of persistent TGF  or 
GDNF treatment for survival. Cells were 
pretreated for 3 h with TGF 3 (2 ng/ml). 
Thereafter, either TGF  was blocked by 
addition of a pan TGF  antibody and 
GDNF (10 ng/ml) was added or only 
GDNF was added in the absence of the 
antibody. Similarly the neurons were 
pretreated with GDNF (10 ng/ml) for 3 h 
and after a washout of GDNF, TGF 3 
(2 ng/ml) was added. As controls, neurons 
were simultaneously treated with GDNF 
and TGF  in the presence or absence of 
the pan TGF  antibody. The surviving neurons were counted after 24 h, each bar represents the mean and standard deviation of two independent 
experiments with every condition tested in triplicate per assay (***, P   0.01). (E) RT-PCR of the GDNF-receptors GFR 1 and Ret and 
immunoblot of GFR 1 using total RNA and protein extracts, respectively, from CG neurons treated for 3 h with TGF  or untreated controls. 
For the immunoblot Neuro2a cells stably expressing GFR 1 were used as positive control. (F) Anti phospho-ERK immunoblot with extracts 
from CG neurons, pretreated with TGF  for the indicated time points and subsequently treated with GDNF for 30 min or left untreated. As 
control for equal loading an immunoblot with an antibody detecting nonphosphorylated ERK was used. 
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TGF  after 3 h did not promote survival. This proved that
the TGF  antibody was present in excess and completely
blocked TGF  activity throughout the culture period.
Please note that a consecutive treatment of first 3 h with
TGF  followed by GDNF was sufficient to attain GDNF-
induced cell survival. Further along this line pretreatment
with GDNF, followed by a change of medium and addition
of TGF  did not elicit a survival promoting effect (Fig. 3
D). Together, these data suggest that GDNF responsiveness
essentially requires pretreatment with TGF .
One possible explanation for this TGF  requirement may
be an effect on the expression of Ret and GFR 1. Therefore,
we investigated the mRNA level of both receptors using
semi-quantitative RT-PCR with primers specific for chicken
Ret and GFR 1 in the presence and absence of TGF . As
shown in Fig. 3 E, there was no change in the amount of
the two receptor mRNAs. Consistent with the unchanged
mRNA level, we found no effect of TGF  pretreatment on
the GFR 1 protein level in a Western blot analysis using a
GFR 1-specific antibody. We next investigated the time de-
pendence for pretreatment with TGF . We found increased
ERK phosphorylation in GDNF-treated neurons after 30
min, which peaked after 3 h and disappeared after 6 h (Fig.
3 F). This kinetics is also indicative of an effect independent
of protein synthesis. One possible explanation could be that
the availability of the GDNF receptors for interaction with
their ligand at the plasma membrane might be regulated by
TGF .
In the presence of a soluble GFR 1, TGF  is not required 
to promote survival and activation of ERK by GDNF
GFR 1 is attached to the outer cell membrane by a GPI
modification (Jing et al., 1996). We have previously shown
that cleavage of this GPI anchor from the membrane by
phosphoinositide-specific phospholipase C disrupts the sur-
vival promoting effect of GDNF and TGF , and that this
effect can be partly reversed by adding TGF  before cleav-
age by phosphoinositide-specific phospholipase C (Kriegl-
stein et al., 1998). This observation strongly argued for an
effect of TGF  on the recruitment of GFR 1 to or its stabi-
lization on the plasma membrane. Therefore, we asked
whether an exogenously added receptor may confer GDNF
responsiveness to CG neurons in the absence of TGF .
To test this hypothesis we added a GFR 1-IgG chimeric
protein to the supernatant of the primary neuron cultures.
Cell counts after 24 h showed that GDNF fully promoted
CG neuron survival in the presence of soluble GFR 1, indi-
cating that addition of TGF  is not required under these
conditions (Fig. 4 A). Thus, TGF  may function by recruit-
ing the GFR 1 by yet unknown mechanisms. Interestingly,
additional treatment with TGF  further increased numbers
of surviving cells, suggesting that TGF  may also affect
components of the GDNF signaling pathway other than
GFR 1. Neutralization of endogenous TGF  resulted in a
minor decrease in survival. Along this line, phosphorylation
of ERK in the presence of soluble GFR 1 also does not re-
quire TGF . However, Akt phosphorylation was only ob-
served if the cells were treated simultaneously with GDNF
and TGF  (Fig. 4 B).
Treatment of CG neurons with Brefeldin A blocks 
activation of the MAPK pathway by GDNF and TGF 
It has been recently shown that GPI-linked molecules con-
stantly cycle between the Golgi apparatus and the plasma
membrane (Nichols et al., 2001). To test whether the shut-
tle of GFR 1 between Golgi and plasma membrane might
be influenced by TGF , we treated CG neurons with
Brefeldin A, a fungal metabolite that causes disassembly of
the Golgi complex and retainment of proteins in the endo-
plasmic reticulum (Nuchtern et al., 1990; Oda et al., 1990).
After pretreatment with TGF  or soluble GFR 1 for
3 h, neurons were exposed to Brefeldin A (2.5  M) for 10
min, and then GDNF was added for another 30 min and
the amount of phosphorylated ERK protein was detected
by Western blot analysis. Brefeldin A completely blocked
GDNF-stimulated phosphorylation of ERK after TGF 
Figure 4. In the presence of a soluble GFR 1 TGF  is not required 
to induce GDNF responsiveness. (A) CG neurons were seeded onto 
PORN/laminine-coated microtiter plates at a density of 3,000 cells 
per well. Cells were treated with combinations of 10 ng/ml GDNF, 
2 ng/ml TGF 3, soluble GFR 1 (sGFR 1, 100 nM), or anti-pan 
TGF  antibody (10  g/ml) as indicated. As a control the neurons 
were left untreated or CNTF (10 ng/ml) was added. (B) Immunoblot 
with a phospho-specific antibodies to Akt and ERK with extracts 
from CG neurons that have been either pretreated with TGF  or a 
soluble GFR 1 for 3 h and where subsequently GDNF or GDNF 
plus TGF  was added for 30 min.162 The Journal of Cell Biology | Volume 159, Number 1, 2002
pretreatment. However, in the presence of soluble GFR 1,
GDNF-induced ERK phosphorylation was only slightly af-
fected by Brefeldin A (Fig. 5). This adds to the notion that
TGF  is required for presenting the GFR 1 to the ligand
on the cell membrane.
TGF  causes clustering of GFR 1 immunoreactivity 
in lipid rafts
We next studied the effect of TGF  on the localization of
the GFR 1 in the plasma membrane of CG neurons. CG
neurons were treated for 3 h with TGF  or left untreated;
subsequently, the medium was removed and the neurons
were incubated with an anti-GFR 1 antibody on ice before
fixation to stain for the receptor at the cell surface of the liv-
ing cells. As shown in Fig. 6 A, in the absence of TGF ,
GFR 1 immunoreactivity is dispersed all over the cellular
surface. After pretreatment with TGF , clusters of receptor
immunoreactivity become visible. As a control for the speci-
ficity of the antibody, the murine neuroblastoma cell line
Neuro2a, which is devoid of GFR 1 (Jing et al., 1996), and
a Neuro2a clone stably transfected with GFR 1 (Neuro2a/
GFR 1), were subject to the same staining procedure. Fig. 6
B demonstrates that wild-type Neuro2a cells display no
GFR 1 immunostaining, whereas Neuro2a/GFR 1 cells
reveal staining of clustered receptors. This is in accordance
with the finding that in these stable transfectants the
GFR 1 protein is predominantly located in lipid rafts at the
plasma membrane (Tansey et al., 2000). The localization of
GFR 1 in lipid rafts can be visualized by double labeling of
the cells with the anti-GFR 1 antibody and an FITC-cou-
pled cholera toxin B which specifically binds to the lipid raft
marker GM1, a cell surface ganglioside (Van Heyningen et
al., 1976; Iwamori et al., 1985). We used Triton extraction
of the cells to visualize detergent-insoluble membrane
compartments as described by Paratcha et al. (2001). In
Neuro2a/GFR 1 cells, GFR 1 is highly colocalized with
GM1 (Fig. 7 A). Using the same labeling procedure for the
CG neurons revealed that there is a markedly enhanced cola-
beling of GFR 1 and GM1 after pretreatment of the cells
with TGF , compared with untreated controls (Fig. 7 B).
This can also be observed if incubation with the antibody for
GFR 1 was performed on the neurons in culture, and
FITC-cholera toxin B was added after fixation (Fig. 7 C).
Taken together, we propose a cooperation of GDNF and
TGF  on the recruitment to, and activation of, the GFR 1
at the plasma membrane. Our data strongly indicate that the
availability of GFR 1 on the cell surface may limit neuronal
survival promoted by GDNF, and that TGF  is involved in
GFR 1 membrane translocation.
Discussion
Response of CG neurons to GDNF requires 
pretreatment with TGF 
In the present study we have analyzed the molecular basis of
GDNF-TGF  cooperativity in primary chick E8 CG neu-
rons. We investigated different putative explanations for the
Figure 5. Treatment with Brefeldin A abolishes ERK phosphorylation 
in TGF  pretreated cells. Immunoblot with a phospho-specific 
antibody to ERK with protein extracts from CG neurons. Cells were 
incubated with Brefeldin A (2.5  M) or vehicle alone for 10 min 
before treatment with TGF  or soluble GFR 1 for 3 h, followed 
by addition of GDNF for 30 min. A quantification of the bands 
representing phosphorylated ERK normalized to total ERK is shown 
in the bar diagram.
Figure 6. Pretreatment of CG neurons with TGF  induces clustering 
of GFR 1 immunoreactivity. (A) Living cells were incubated with a 
GFR 1 antibody for 1 h on ice and then fixed with 4% PFA before 
secondary antibody treatment. In the absence of TGF  GFR 1 
immunoreactivity is evenly distributed on the cell surface of two 
representative cells. After incubation with TGF  (2 ng/ml) for 3 h 
GFR 1 immunoreactivity is clustered in a patch-wise fashion. 
Bars, 5  M. (B) Specificity of GFR 1 antibodies was ascertained by 
staining wild-type Neuro2a cells, which lack GFR 1 receptors, and 
Neuro2a cells transfected with a GFR 1 construct. Bars, 10  M. Cooperative effect of GDNF and TGF  | Peterziel et al. 163
GDNF-TGF  synergism at the following levels of GDNF
signaling: (a) with regard to signaling cascade components;
(b) at the receptor expression level; and (c) at the level of
translocation of GFR 1 to lipid rafts. Using specific inhibi-
tors proved that the major portion of the survival promot-
ing effect of GDNF in our system is mediated via the ERK/
MAP kinase pathway. A prerequisite for GDNF activity is
pretreatment of the cells with TGF , both with regard to
ERK phosphorylation and to survival. After the initial pre-
treatment, continuous presence of TGF  is no longer re-
quired. Concerning activity of PI3 kinase as measured by
phosphorylation of its target Akt, the requirement for
TGF  is different in that a simultaneous addition of both
GDNF and TGF  is necessary. However, inhibition of PI3
kinase activity only has a minor effect on survival. The dif-
ference between our results presented here and previous ob-
servations on the effect of PI3 kinase inhibition (Krieglstein
et al., 1998) can be explained by the fact that we excluded
insulin from the culture medium. The rationale for this ex-
clusion was that insulin also promotes survival of CG neu-
rons and is known to signal via the PI3 kinase pathway.
However, as we show here, the GDNF-TGF  cooperativity
is not dependent on the presence of insulin. The physiolog-
ical relevance of Akt phosphorylation and the underlying
molecular mechanisms of the TGF -GDNF synergism re-
main to be clarified.
Figure 7. GFR 1 colocalizes with a marker for 
lipid rafts in the presence of TGF . (A) Neuro2a 
cells transfected with a GFR 1 construct were 
Triton-extracted and fixed with 4% PFA before 
staining with an antibody to GFR 1 and cholera 
toxin (CTX), which specifically binds to the lipid 
raft ganglioside GM1. The merged images shows 
colocalization of GFR 1 immunoreactivity and 
CTX. Bars, 10  M. (B) CG neurons were either 
treated with TGF  (2 ng/ml) for 3 h or left 
untreated. Cells were processed and stained as 
described in (A). In the presence of TGF  colocal-
ization of GFR 1 and CTX is increased. Bars, 5  M. 
(C) CG neurons were either treated with TGF  
(2 ng/ml) for 3 h or left untreated. Living cells were 
incubated with GFR 1 antibody for 1 h on ice 
and fixed with 4% PFA before incubation with a 
secondary antibody to GFR 1 and CTX. Note 
copatching of GFR 1 and CTX after treatment 
with TGF . Bars, 5  M.164 The Journal of Cell Biology | Volume 159, Number 1, 2002
TGF  treatment induces clustering of GFR 1 in lipid 
microdomains on the cell surface
TGF  induction of GDNF responsiveness occurred within
30 min, excluding an effect that is dependent on new pro-
tein synthesis. Consistently, TGF -induced GDNF respon-
siveness did not involve upregulation of expression of the re-
ceptors cRet and GFR 1. Our data suggest that TGF  does
affect the availability of GFR 1 for the ligand GDNF. This
is shown by the following: (a) the inhibitory effect of BFA
on ERK phosphorylation; (b) the clustering of GFR 1 im-
munoreactivity and the costaining of GFR 1 and the lipid
raft marker GM1; and (c) preliminary observations that
TGF  pretreatment leads to a shift of GFR 1 from cyto-
plasmic to membrane fractions of CG neuron protein ex-
tracts (unpublished data).
It has been shown that GFR 1 is necessary to recruit Ret to
lipid rafts, which attenuates downstream signaling pathways
as well as neuronal differentiation and survival (Tansey et al.,
2000; Paratcha et al., 2001). Lipid rafts are thought to repre-
sent specialized signaling organelles within the plasma mem-
brane because of an enrichment of many adaptor and signal-
ing molecules (Anderson, 1998). Tansey et al. (2000) have
analyzed the functional importance of the GPI anchorage of
GFR 1 in mediating GFR 1/Ret signalling. They were able
to show that both the anchored and the soluble GFR 1 me-
diate Ret translocation to lipid rafts, and thereby attenuate
downstream kinase activity. Paratcha et al. (2001) extended
these studies by providing additional evidence, suggesting
that Ret-translocation is best mediated by soluble GFR 1,
which may be provided by ectopic sources. Most studies ad-
dressing GFR 1/Ret interaction have been performed using
cell lines which were transfected with either GFR 1 alone or
both GFR 1 and Ret. In this context, the overexpressed GPI-
linked receptor is constitutively present in the lipid raft frac-
tion on the cellular membrane. So far, it has not been ad-
dressed whether the presence of endogenous GFR 1 at the
plasma membrane might be subject to regulation. It has been
shown that GPI-linked proteins continuously shuttle between
the Golgi complex and the plasma membrane without in-
volvement of new synthesis of this proteins (Nichols et al.,
2001). Regulation of this cycling might thus play an impor-
tant role in lipid raft associated signaling cascades.
Mechanisms of TGF -induced recruitment of GFR 1 
to its active site at the plasma membrane
There are several possible ways that TGF  may be mediat-
ing the availability of GFR 1 at lipid rafts. First, it has to be
clarified whether TGF  is acting via its receptors, T RI and
T RII, and whether downstream signaling of TGF  is re-
quired. GDNF-TGF  cooperativity might also involve a di-
rect interaction of the corresponding receptors at the plasma
membrane. Furthermore, cooperativity could be due to an
indirect effect involving a protein for which the receptors
compete. One example for such a competition has been
shown for binding of caveolin-1 to the NGF receptors TrkA
and p75 which determines the NGF response of PC12 cells
(Bilderback et al., 1999). Caveolin-1 is a principal com-
ponent of cholesterol-enriched plasma membrane micro-
domains, called caveolae, which are involved in vesicular
transport and signal transduction (for review see Schlegel
and Lisanti, 2001). It has been proposed that caveolin could
function as a transmembrane adaptor molecule that couples
GPI-linked proteins with signaling molecules during GPI-
membrane trafficking or GPI-mediated signal transduction
events (Sargiacomo et al., 1993).
It has been shown that T RI interacts with caveolin-1,
and that upon binding of TGF  to its receptors at the mem-
brane, this interaction is increased and leads to downregula-
tion of the TGF  response, possibly by internalization of
T RI (Razani et al., 2001). Whether a similar interaction of
GFR 1 with caveolin-1 occurs and whether this is changed
in the presence of TGF  remains to be established.
Cooperative effects of GDNF with other factors on the 
survival of different neuronal populations
The requirement of a synergism between GDNF and an-
other factor for the survival of specific neuronal populations
has been described for BDNF (sensory neurons of the
nodose-petrosal ganglion complex; Erickson et al., 2001),
CNTF (mouse photoreceptors; Ogilvie et al., 2000), IGF-I
(motoneurons; Bilak and Kuncl, 2001; Bilak et al., 2001),
osteogenin-1/bone morphogenetic protein 7, a member of
the TGF  superfamily (explanted embryonic chicken gan-
glia and dissociated ganglionic neuron; Bengtsson et al.,
1998), and cardiotrophin-1 (embryonic rat motoneurons;
Arce et al., 1998). These findings underline the importance
of modulation of the GDNF response by other (growth) fac-
tors, but the mechanistic explanation for any of these syner-
gisms has yet to be provided.
Interference between TGF  signaling and signal 
transduction through receptor tyrosine kinases
In contrast to GDNF synergisms, molecular mechanisms of
interaction of TGF  family members with other signaling
cascades have been studied in various cellular systems. Inter-
feron-  inhibits TGF -induced phosphorylation of Smad3
and downstream TGF  effects by an effect involving new
protein synthesis, namely by induction of the expression of
the antagonistic SMAD, Smad7, through Jak1 and Stat1 (Ul-
loa et al., 1999). Synergistic effects involving direct interaction
of Stat proteins and Smads have been reported for Smad3 (ac-
tivated by TGF ) and STAT3 (activated by Interleukin-6) in
the Hep3B hepatoma cell line (Yamamoto et al., 2001) and
for Smad1 (activated by bone morphogenetic protein 2) and
STAT3 (activated by leukemia inhibitory factor) on primary
fetal neural progenitor cells during the induction of astrocyte
differentiation (Nakashima et al., 1999). These activities were
due to physical interactions between STAT3 and the Smads
bridged by the transcriptional coactivator p300.
Evidence for inhibitory effects of receptor tyrosine kinase
pathways on signaling of members of the TGF  family con-
cerns the level of signal transduction through phosphory-
lated Smads. It has been shown that EGF and hepatocyte
growth factor exhibit an inhibitory effect on bone morpho-
genetic protein–induced Smad1 activation by phosphoryla-
tion of specific serines in the linker region of Smad1. This
phosphorylation is catalysed by the MAPK ERK in mink
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our findings of a TGF -GDNF cooperativity, in these cases
the cells receive opposing regulatory inputs through the re-
ceptor tyrosine kinases and the serine/threonine kinase.
There are also reports about how receptor tyrosine kinases
(RTKs) or downstream kinases can positively interfere with
the TGF  signaling cascade. For example, in contrast to
their above described inhibitory effect, hepatocyte growth
factor and EGF have been shown to induce Smad2 phosphor-
ylation and nuclear translocation in epithelial cells in the
absence of TGF  and independent of TGF  receptors (de
Caestecker et al., 1998). These observations suggest that the
quality of interference of RTK- and TGF -induced path-
ways is dependent on the context of the analyzed cellular sys-
tem. In contrast to all these observations in which RTK sig-
naling positively affects TGF  signaling, in our neuronal
model, TGF  facilitates RTK signaling, primarily by exert-
ing an effect on the GFR 1 receptor. Whether there also ex-
ists a physical interaction of downstream effectors of TGF 
and GDNF which could explain the differential TGF  re-
quirement for Akt phosphorylation needs to be examined.
Interaction of Smads with other transcription factors 
on the promoter level
Cooperativity of the TGF  signaling pathway with other
pathways has also been described to involve regulation of
ligand-induced gene transcription at the promoter level. A
nuclear Smad3/Smad4 can activate a TPA responsive gene
promoter element directly or through interaction with both
c-Jun and c-Fos (Zhang et al., 1998). Smad3 has also been
reported to potentiate ligand-induced transactivation of the
vitamin D receptor as a coactivator through binding of the
steroid receptor coactivator-1 protein in the nucleus (Yanagi
et al., 1999; Yanagisawa et al., 1999) or by binding to a
Smad binding element adjacent to a vitamin D receptor
binding element on the human osteocalcin promoter (Su-
bramaniam et al., 2001). In human neuroblastoma cells,
CNTF and TGF  synergistically induce vasoactive intes-
tinal peptide (VIP) mRNA expression and transcription
through the cytokine response element in the VIP promoter.
This synergy is dependent on binding of Smad, STAT, and
AP-1 to distinct sites within the VIP promoter. Whether any
physical interaction of the signaling components is necessary
has not been analyzed in this report (Pitts et al., 2001).
As discussed above, crosstalks of TGF  family members
with other signaling pathways have been described to occur
both in the cytosol and the nucleus (for review see Wrana,
2000). Our finding that TGF  cooperativity also involves mo-
lecular interactions at the plasma membrane adds a new point
of view to signaling interactions of RTKs and TGF  signaling.
In conclusion, our data show for the first time that TGF 
signaling facilitates tyrosine kinase signaling by modulating
the availability of the GDNF receptor on the cell surface.
TGF -mediated recruitment of the GFR 1 is crucial for
GDNF-dependent signaling and survival.
Materials and methods
Cell culture and preparation of protein extracts
Fertilized white Leghorn chicken eggs were incubated in a humidified egg
chamber at 37.8 C. Embryonic chick (E8) CG were dissected, freed from
nerve roots, and connective tissue, and collected in Ca2 /Mg2 -free
HBSS (CMF; Sigma-Aldrich). Ganglia were trypsinized, washed in CMF,
and triturated as described (Lachmund et al., 1994). Single cell suspen-
sions were seeded onto poly-L-ornithine (PORN), laminine-coated plates
or coverslips in DME supplemented with N1 additives w/o insulin (Botten-
stein and Sato, 1980), 0.25% BSA (Sigma-Aldrich), and incubated at 37 C
in a 5% CO2 and 95% air atmosphere (Lachmund et al., 1994).
The cell line Neuro2a was cultured in DME medium containing 10%
bovine calf serum, 100 U/ml penicillin, 0.50  g/ml streptomycin, 100  g/
ml neomycin (Invitrogen) and 1% nonessential amino acids. The stably
transfected Neuro2a-GFR 1 clone, provided by M. Saarma (University of
Helsinki, Helsinki, Finland) was cultured in RPMI containing 10% bovine
calf serum, 100 U/ml penicillin, 0.50  g/ml streptomycin and 250  g/ml
G418. Total cell lysates were obtained by solubilizing the cells in Laemmli
sample buffer (80 mM Tris, pH 6.8, 2% SDS, 10% glycerol, 2%  -mercap-
toethanol, 0.01% bromophenol blue) and sonication.
Evaluation of cell survival
CG neurons were seeded onto PORN/laminine-coated microtiter plates (A/2;
Costar) at a density of 3,000 cells per well with or without different re-
combinant neurotrophic factors CNTF, GDNF, FGF2, and TGF 3. In the ex-
periments where 5  g/ml insulin was added to the culture medium, 1,000
cells were seeded per well. The recombinant GFR 1/Fc chimera (soluble
GFR 1) was obtained from R&D and applied in a concentration of 100 nM.
The concentrations of the kinase inhibitors were as follows: Wortmannin
(Calbiochem) 100 nM; PD98059 (Calbiochem) 50  M; LY294002 (Calbio-
chem) 5  M; and U0126 (Promega) 10  M. After 24 h, cultures were fixed
by addition of 2.5% glutaraldehyde in PBS. Numbers of surviving neurons
were determined by direct counting using phase contrast microscopy.
Immunoblotting
The cells were allowed to attach to the PORN/laminine-coated dishes for
at least 2 h and treated as indicated. Total cell lysates were subjected to a
8–10% SDS polyacrylamide gel electrophoresis and electroblotted onto ni-
trocellulose membranes. For detection of proteins the membranes were in-
cubated with the specific antibodies, prior to the addition of the corre-
sponding secondary antibody conjugated to horseradish peroxidase and
detection by the enhanced chemoluminescence method (ECL; Amersham
Biosciences). The antibodies were obtained from different sources as fol-
lows: anti–phospho-ERK and anti-ERK2 from Santa Cruz Biotechnology;
anti–phospho-Akt (Ser-437) from New England Biolabs; biotinylated anti-
GFR 1 antibody from R&D Systems; and streptavidine-coupled horserad-
ish peroxidase from Amersham Biosciences. Quantification of immunore-
active bands was performed with Scion Image software and statistics
performed with Excel.
Measurement of GFR 1 and cRet mRNA levels
Total RNA was extracted from neurons that had been cultured in the pres-
ence and absence of TGF  using Total RNA reagent (Biomol) according to
the manufacturer’s protocol. Three micrograms of RNA were reverse tran-
scribed with MMLV-RT (Promega) in a 50  l reaction containing the man-
ufacturer’s buffer supplemented with 0.8 mM dNTPs and 0.02  g/ l ran-
dom hexanucleotides. Aliquots of 4  l of the reverse transcription reaction
were used for amplification in 30  l PCR reactions with the following spe-
cific forward and reverse primers: GFR 1 forward: 5 -TTGACAAAGTTC-
CCCCAAAG-3 ; GFR 1 reverse: 5 -GTTCGGTGTCATCACTGTGC-3 ; Ret
forward: 5 -GATGCTGTCGTGGAGTTCAA-3 ; Ret reverse: 5 -TCGT-
TCACCAAAACATCCAA-3 ;   -actin forward: 5 -CCAGCCATCTTTCTTG-
GGTA-3 ; and  -actin reverse: 5 -GCGCATTTATGGGTTTTGTT-3 .
Immunocytochemistry
Staining for GFR 1 was done with a biotinylated anti-rat GFR 1 antibody
(R&D) for either 2 h on ice prior to fixation of the cells with 4% PFA or af-
ter extraction with Triton X-100. In the latter case cells were washed in
PBS, incubated on ice in buffer (2 mM MgCl2, 10 mM EGTA, 60 mM
Pipes, pH 7) and extracted for 8 to 9 min on ice with 1% Triton X-100 di-
luted in MSB buffer (Ledesma et al., 1998). The cells were washed with
cold MSB and fixed with 4% PFA. After washing a secondary biotinylated
antibody was added and immunoreactivity was detected by adding
streptavidin-Cy3. For visualization of the lipid raft marker GM1 the cells
were then labeled for 45 min with 0.1  g/ml of fluorescein-conjugated
cholera toxin B fragment (Sigma-Aldrich) in PBS with 0.1% BSA, washed
with PBS, and mounted in mounting solution.
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